What is Zhengye Biotechnology Holding Limited (ZYBT)?

Zhengye Biotechnology Holding Limited (ZYBT) is a stock in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. View full analysis on Stocks360.

What is the current price of ZYBT?

The current price of ZYBT is $1.30. Prices are updated in real time on Stocks360.

What is ZYBT's price-to-earnings (PE) ratio?

ZYBT's trailing twelve-month PE ratio is -4.46, based on current price and earnings per share data available on Stocks360.

What is ZYBT's market capitalization?

ZYBT's market capitalization is $61,608,789.00, placing it in the small-cap tier.

Zhengye Biotechnology Holding Limited (ZYBT)

Stock analysis · NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic

$1.30

Market Cap

$61.61M

PE (TTM)

-4.46

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

-2.29

Day Range

$1.17 – $1.32

52-wk Range

$0.62 – $8.01

Avg Volume

N/A

Volume

122.70K

Zhengye Biotechnology Holding Limited (ZYBT) is a publicly traded company in the Healthcare sector. Latest price: $1.30. Market cap $61.61M. Trailing PE -4.46. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-31 · $2.46 2026-10-30 · $1.30 (-47.15%)

Proprietary Signals

Signal snapshot temporarily unavailable.

About Zhengye Biotechnology Holding Limited

Zhengye Biotechnology Holding Limited specializes in the creation, manufacturing, and commercialization of animal health immunizations. The company primarily supplies the Chinese agricultural sector with vaccines tailored for a broad spectrum of farm animals, including swine, bovines, goats, ovines, and poultry. Additionally, its product range encompasses inoculations for canines. Beyond its domestic reach, the firm also distributes its offerings to international markets, notably exporting to Vietnam, Pakistan, and Egypt. Established in 2004, this enterprise bases its principal operations in Jilin, China, and operates as a subsidiary entity of Securingium Holding Limited.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-4.46×
P/S (TTM)	3.69×
P/B	1.64×
P/FCF (TTM)	12.82×
EV / EBITDA	-8.75×
EV / Sales	3.91×
Earnings Yield	-20.03%
Free Cash Flow Yield	7.80%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$434.70M
Revenue (TTM)	$111.22M
Net Income (TTM)	-$82.12M
Free Cash Flow (TTM)	$18.74M
Net Debt	$24.75M
Working Capital	$16.94M
Gross Margin	14.69%
Operating Margin	-68.43%
Net Margin	-73.84%
Return on Equity	-30.85%
Return on Invested Capital	-19.93%